Delay in Clover Trail Power Software Delivery May Delay Windows-Powered Tablets
Delay in Clover Trail Power Software Delivery May Delay Windows-Powered Tablets

Intel is still failing to deliver the Clover Trail power management software to Microsoft, a recent report has uncovered, and therefore the launch of Windows-powered tablets is being estimated to face a further delay.

It has been found that the software for the Clover Trail processors, a low-power hardware platform, is to be run by the tablets. Clover Trail is also dubbed as Atom Z2760, which is built using 32-nanometer high-k process of Intel.

The report finds that the 1.8GHz dual-core x86 CPU's primary feature is its better battery life. A person, unnamed, believes that a further delay in the tablets' release means delay by Microsoft in approval of any tablets that feature the Clover Trail low-power silicon.

Clover Trail helps tablets sit somewhere closer to iPad when it comes to form factor and price. Though, varied OEMs, including the Acer Iconia W510, HP Envy X2 and the Asus Vivo Tab, have brought hardware with the Clover Trail hardware. But, as per the findings, Microsoft's delay may mean a no-show of these devices during the launch of Windows 8.

The same has been decided later this month. Sources say, "We'll see in a few weeks if this delay in getting the power management drivers to Microsoft will result in delays in Clover Trail based hardware being released".

Latest News

Mentally Disturbed Pregnant Woman wants Medical Abortion
Rise in Complaints and Complication for Social Workers by Cap on care Expenditur
GPs’ Chief inspector to be Appointed Soon
Babies Sharing Beds with Parents Under Threat of Cot deaths
High Intake of Saturated and Unsaturated Fat Can Increase Risk of AMD
Australian History Might be Re-Written as an Outcome of an Ancient Discovery
The Opportunity Rover of NASA Ruined the 40-Year-Old Record of Lengthiest Extrat
NASA Telescope Kepler Might Get Terminated Forever
Some Big News Coming
Dark-Skinned People also Vulnerable to Skin Cancer
Price Disclosure Delivers Almost 70% of $18 Billion of Savings by 2017-18